Expression of endoglin in the transition between psoriatic uninvolved and involved skin

Acta Dermato-Venereologica

Volumn 78, Issue 1, 1998, Pages 19-21

  Van De Kerkhof, P C M ^a   Rulo, H F C ^a   Van Pelt, J P A ^a   Van Vlijmen Willems, I M J J ^a   De Jong, E M G J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; KERATINOCYTE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; T LYMPHOCYTE;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INFLAMMATION; MALE; MIDDLE AGED; PSORIASIS; RECEPTORS, CELL SURFACE; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0031913790     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015559850135760     Document Type: Article

References (17)

1. Gougos A, St Jaques S, Greaves MA, O'Conell PJ, d'Apice AJF, Bühring HJ, et al. Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells and syncytiotrophoblasts. Int Immunol 1992; 4: 83-92.
2. Cheifetz S, Bellón T, Calés C, Vera S, Bernabeu C, Massagué J, et al. Endoglin is a component of the TGF-β receptor system in human endothelial cells. J Biol Chem 1992; 267: 19027-19030.
3. Cai JP, Falanga V, Tailor JR, Chin Y-H. Transforming growth factor bèta differentially regulates the adhesiveness of normal and psoriatic dermal microvascular endothelial cells for peripheral blood mononuclear cells. J Invest Dermatol 1992; 98: 405-409.
4. Hendriksen R, Gobl A, Wilander E, Oberg K, Miyazono K, Funa K. Expression and prognostic significance of TGF-beta isotypes, latent TGF-beta binding protein. TGF-beta type I and type II receptors, and endoglin in normal ovary and ovarian neoplasms. Lab Invest 1995; 73: 213-220.
5. Yamada N, Kato M, Yamashita H, Nister M, Miyazono K, Heldin CH, et al. Enhanced expression of transforming growth factor-beta and its type-I and type-II receptors in human glioblastoma. Int J Cancer 1995; 62: 386-392.
6. Szekanecz Z, Haines GK, Harlow LA, Shah MR, Fong TW, Fu R, et al. Increased synovial expression of transforming growth factor (TGF)-beta receptor endoglin and TGF-beta 1 in rheumatoid arthritis; possible interactions in the pathogenesis of the disease. Clin Immunol Immunopathol 1995; 76: 187-194.
7. Westphal JR, Willems HW, Schalkwijk CJM, Ruiter DJ, de Waal RMW. A new 180 KD dermal endothelial cell activation antigen: in vitro and in situ characteristics. J Invest Dermatol 1993; 100: 27-34.
8. 2 activity is raised in the uninvolved epidermis of psoriasis. Br J Dermatol 1983; 108: 103-106.
9. Ziboh VA, Casebolt TL, Marcelo CL, Voorhees JJ. Biosynthesis of lipoxygenase products by enzyme preparations from normal and psoriatic skin. J Invest Dermatol 1984; 83: 426-430.
10. 4. J Invest Dermatol 1985; 84: 421-423.
11. 4 in healthy and psoriatic skin. Br J Dermatol 1987; 116: 521-524.
12. Rulo HFC, Westphal JR, van de Kerkhof PCM, de Waal RMW, van Vlijmen IMJJ, Ruiter DJ. Expression of endoglin in psoriatic involved and uninvolved skin. J Derm Sci 1995; 10: 103-109.
13. Ruiter DJ, Schlingemann RO, Rietveld FJR, de Waal RMW. Monoclonal antibody defined human endothelial antigens as vascular markers. J Invest Dermatol 1989; 93: 25S-32S.
14. Schlingemann RO, Dingjan GM, Emeis JJ, Blok J, Warnaar SO, Ruiter DJ. Monoclonal antibody PAL-E specific for endothelium. Lab Invest 1985; 52: 71-76.
15. Kerkhof van de PCM, van Rennes H, de Grood R, Bauer FW, Mier PD. Metabolic changes at the margin of the spreading psoriatic lesion. Br J Dermatol 1983; 108: 647-652.
16. Jong de EMGJ, Schalkwijk J, van de Kerkhof PCM. Epidermal proliferation and differentiation, composition of the inflammatory infiltrate and the extracellular matrix in the margin of the spreading psoriatic lesion. Eur J Dermatol 1991; 1: 221-227.
17. Hull MS, Goodfield M, Wood EJ, Cunliffe WJ. Active and inactive edges of psoriatic plaques: identification by tracing and investigation by laser-Doppler flowmetry and immunohistochemical techniques. J Invest Dermatol 1989; 92: 782-785.